Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 3.91x is 69% below its 5-year average of 12.76x, near the low end of its 5-year range (0.76x–31.92x).
5.22% above its 12-month average of 3.72x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): 3.69x.
INTEREST COVERAGE RATIO
3.91x
INTEREST COVERAGE RATIO AVG TTM
3.72x
INTEREST COVERAGE RATIO AVG 3Y
10.75x
INTEREST COVERAGE RATIO AVG 5Y
12.76x
INTEREST COVERAGE RATIO AVG 10Y
14.96x
INTEREST COVERAGE RATIO AVG 15Y
14.27x
INTEREST COVERAGE RATIO AVG 20Y
14.30x
CURRENT VS TTM AVG
+5.22%
CURRENT VS 3Y AVG
-63.61%
CURRENT VS 5Y AVG
-69.36%
CURRENT VS 10Y AVG
-73.86%
CURRENT VS 15Y AVG
-72.61%
CURRENT VS 20Y AVG
-72.66%
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+161.33%
vs the sector median at left
Bruker Corporation
Market Cap
$9.22B
Interest Coverage Ratio
3.91x
TTM Avg
3.72x
3Y Avg
10.75x
5Y Avg
12.76x
Market Cap
$9.33B
Interest Coverage Ratio
5.94x
TTM Avg
6.59x
3Y Avg
5.07x
5Y Avg
3.90x
Market Cap
$8.93B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$8.94B
Interest Coverage Ratio
-25.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.91B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.68B
Interest Coverage Ratio
5.05x
TTM Avg
5.30x
3Y Avg
10.04x
5Y Avg
14.14x
Market Cap
$9.67B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.71B
Interest Coverage Ratio
-1403.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bruker Corporation (BRKR) | $9.22B | 3.91x | 3.72x | 10.75x | 12.76x |
| Insulet Corp. (PODD)vs › | $9.33B | 5.94x | 6.59x | 5.07x | 3.90x |
| Bruker Corporation (BRKRP)vs › | $8.93B | 3.91x | 4.60x | 15.68x | 18.14x |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.94B | -25.81x | N/A | N/A | N/A |
| Vaxcyte, Inc. (PCVX)vs › | $9.66B | N/A | N/A | N/A | N/A |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.91B | N/A | N/A | N/A | N/A |
| Henry Schein, Inc. (HSIC)vs › | $9.68B | 5.05x | 5.30x | 10.04x | 14.14x |
| Krystal Biotech, Inc. (KRYS)vs › | $9.67B | N/A | N/A | N/A | N/A |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.71B | -1403.21x | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.65B | 1.10x | 1.10x | 1.10x | 1.10x |
Interest Coverage
3.9x
Debt/Equity
0.80
Current Ratio
1.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 3.69x |
| 2025-12-31 | 9.98x |
| 2025-09-30 | 1.72x |
| 2025-06-30 | 0.76x |
| 2025-03-31 | 2.43x |
| 2024-12-31 | 4.62x |
| 2024-09-30 | 5.87x |
| 2024-06-30 | 3.06x |
| 2024-03-31 | 12.96x |
| 2023-12-31 | 23.52x |
| 2023-09-30 | 31.92x |
| 2023-06-30 | 22.10x |
| 2023-03-31 | 17.04x |
| 2021-09-30 | 25.73x |
| 2021-06-30 | 15.29x |
| 2021-03-31 | 23.45x |
| 2020-12-31 | 49.08x |
| 2020-09-30 | 20.82x |
| 2020-06-30 | 14.70x |
| 2020-03-31 | 8.63x |
| 2019-12-31 | 37.53x |
| 2019-09-30 | 18.68x |
| 2019-06-30 | 14.46x |
| 2019-03-31 | 13.52x |
| 2018-12-31 | 24.74x |
| 2018-09-30 | 30.04x |
| 2018-06-30 | 18.77x |
| 2018-03-31 | 11.21x |
| 2017-12-31 | 21.79x |
| 2017-09-30 | 13.86x |
| 2017-06-30 | 8.82x |
| 2017-03-31 | 10.16x |
| 2016-12-31 | 20.24x |
| 2016-09-30 | 13.50x |
| 2016-06-30 | 7.03x |
| 2016-03-31 | 10.97x |
| 2015-12-31 | 18.61x |
| 2015-09-30 | 9.40x |
| 2015-06-30 | 10.19x |
| 2015-03-31 | 4.90x |
| 2014-12-31 | 11.13x |
| 2014-09-30 | 1.53x |
| 2014-06-30 | 11.42x |
| 2014-03-31 | 6.87x |
| 2013-12-31 | 15.25x |
| 2013-09-30 | 9.84x |
| 2013-06-30 | 14.03x |
| 2012-12-31 | 10.89x |
| 2012-09-30 | 22.33x |
| 2012-06-30 | 6.14x |
| 2012-03-31 | 9.83x |
| 2011-12-31 | 21.48x |
| 2011-09-30 | 22.06x |
| 2011-06-30 | 24.19x |
| 2011-03-31 | 17.13x |
| 2010-12-31 | 32.25x |
| 2010-09-30 | 32.75x |
| 2010-06-30 | 29.15x |
| 2010-03-31 | 17.93x |
| 2009-12-31 | 58.62x |
| 2009-09-30 | 14.44x |
| 2009-06-30 | 9.62x |
| 2009-03-31 | 6.22x |
| 2008-12-31 | 2.43x |
| 2008-09-30 | 4.45x |
| 2008-06-30 | 8.06x |
| 2008-03-31 | 1.29x |
| 2007-12-31 | 41.33x |
| 2007-09-30 | 15.74x |
| 2007-03-31 | 12.70x |
| 2006-09-30 | 14.77x |
| 2005-03-31 | 12.89x |
| 2004-12-31 | 2.07x |
| 2004-09-30 | 0.13x |
| 2004-06-30 | -5.36x |
| 2003-09-30 | -36.49x |
| 2003-06-30 | 4.10x |
| 2003-03-31 | -5.71x |
| 2002-12-31 | 0.24x |
| 2002-09-30 | 166.06x |